NTVO - jaargang 19, nummer 5, augustus 2022
L.C. Steggink
Op 2 maart 2022 promoveerde Lars Steggink aan de Rijksuniversiteit Groningen op zijn proefschrift, getiteld ‘Long-term outcome and treatment-related toxicity in patients with breast and testicular cancer’. Promotores waren prof. dr. J.A. Gietema (afdeling Medische Oncologie, Universitair Medisch Centrum Groningen (UMCG)) en prof. dr. ir. F.E. van Leeuwen (afdeling Psychosociaal Onderzoek & Epidemiologie, Nederlands Kankerinstituut-Antoni van Leeuwenhoek (NKI-AVL)). De belangrijkste bevindingen worden hieronder beschreven.
(NED TIJDSCHR ONCOL 2022;19:202–4)
Lees verderTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.